SCHEMBL1164489

SCHEMBL1164489

O=CC12CCC(CC(=O)C1)N2C(=O)OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
HTR2C P28335 1/20 0.41
GAA P10253 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 2/20 0.40
ELANE P08246 3/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
GLA P06280 1/20 0.39
F2 P00734 2/20 0.39
CTSG P08311 1/20 0.39
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26115372 0.87 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9AHTR2CGAA
SCHEMBL25417193 0.74 HTT (0.42) SMN1; SMN2NPC1RAB9AHTR2CCYP2C19
SCHEMBL14609981 0.72 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9AHTR2CGAA
SCHEMBL5118035 0.72 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AHTR2CGAA
SCHEMBL154134 0.72 HTR2C (0.55) SMN1; SMN2NPC1RAB9AHTR2CCYP2C19
SCHEMBL12094663 0.72 HTR2C (0.55) SMN1; SMN2NPC1RAB9AHTR2CCYP2C19
SCHEMBL26113894 0.71 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9AHTR2CGAA
SCHEMBL5122115 0.70 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9AHTR2CGAA
SCHEMBL204928 0.70 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9AHTR2CGAA
SCHEMBL1012858 0.70 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9AHTR2CGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011018796-A1 AN IMPROVED PROCESS FOR THE SYNTHESIS OF ALKYL/ARALKYL (2S)-2-(TERT-BUTOXYCARBONYL)-AMINO-2-[-8-AZABICYCLO[3.2.1]OCT-3-YL]-EXO-ACETATE AND ANALOGS THEREOF: KEY INTERMEDIATES FOR THE PREPARATION OF DPPIV INHIBITORS LUPIN LIMITED (IN) 2011-02-17 WO claimed